![]()
![]() Zoetis Reports First-Quarter 2013 Results US - Zoetis, formerly the animal health business of Pfizer Inc., has reported its financial results for... European Pig Meat Industry Facing Its Challenges EU - The European pig meat industry is facing its challenges with issues such as regulations on sow pens... Zoetis Looks to the Future GLOBAL - Zoetis is the new name for Pfizer Animal Health following an initial public offering (IPO) on... Growing Importance of Emerging Markets GLOBAL - The emerging markets are becoming an increasingly important focus for global companies, according...
DRAXXINEXCEDE For Swine RESPISURE/ RESPISURE ONE LINCOMIX FluSure XP FARROWSURE GOLD EXCENEL Fostera PCV Fostera PRRS ALBAC AUREO S-P 250 AUREOMYCIN BMD Individual Pig Care - It's The Right Thing To Do. Husbandry Education
Health and Performance Improvements of Pigs Treated with DRAXXIN® (tulathromycin) Injectable Solution for Swine Respiratory Disease Under Field ConditionsPerformance and Health Improvements of Pigs Treated with DRAXXIN® (tulathromycin) Injectable Solution: A Mycoplasma hyopneumoniae Challenge Model FluSure XP™: Research-Backed Swine Influenza Virus (SIV) Vaccine for Combating Rapidly Evolving SIV Viruses What's New With Swine Flu? By Michael Kuhn, DVM, Pfizer Animal Health. FarrowSure® GOLD B: Profiling efficacy and safety of a new, reformulated 2-mL dose vaccine Clinical and economic effects of lincomycin in-feed (Lincomix®) and/or a porcine proliferative enteropathy (ileitis) vaccine (Enterisol® Ileitis) in pigs challenged with Lawsonia intracellularis Comparative study demonstrates RespiSure® reduces clinical signs, lung lesions, and production losses in swine co-infected with M. hyopneumoniae and PCV2 Draxxin® (tulathromycin) Injectable Solution: Duration of effectiveness in an Actinobacillus pleuropneumoniae challenge model
Product Information contained on this page applies to the United States only.For other countries please refer to your local representatives. |












Product Information contained on this page applies to the United States only.
© 2000 - 2012. 5m Publishing, Benchmark House, 8 Smithy Wood Drive, Sheffield, S35 1QN, England.